News
Day for drug tariffs ticks closer, the pharmaceutical industry doesn’t know what to think.The Trump administration said in ...
Goldman Sachs keeps Neutral on Pfizer, citing unclear product growth plans and focus on M&A amid changing market valuations ...
Nevertheless, Albert Bourla has been lobbying the U.S. government—as high as President Donald Trump himself—to skip the ...
Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...
Pfizer is raising the bar for its sweeping cost-savings drive yet again, this time cranking up the total target to $7.7 ...
Pfizer’s R&D organization has been in flux for almost two years now, since the $43 billion acquisition of ADC specialist ...
3don MSN
Here's a list of the companies that have announced new U.S. investments since Trump took office: Merck on Tuesday said it is ...
Miky Lee, producer behind Oscar-winning 'Parasite', is set to be honored with the Ellis Island Medal of Honor. She joins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results